Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion

A. Yamagata (Okayama, Japan), M. Arita (Okayama, Japan), F. Tokioka (Okayama, Japan), C. Sugimoto (Osaka, Japan), H. Sumikawa (Osaka, Japan), T. Tanaka (Hyogo, Japan), H. Yasui (Shizuoka, Japan), T. Fujisawa (Shizuoka, Japan), Y. Nakamura (Shizuoka, Japan), T. Suda (Shizuoka, Japan), T. Ishida (Okayama, Japan)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 824
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yamagata (Okayama, Japan), M. Arita (Okayama, Japan), F. Tokioka (Okayama, Japan), C. Sugimoto (Osaka, Japan), H. Sumikawa (Osaka, Japan), T. Tanaka (Hyogo, Japan), H. Yasui (Shizuoka, Japan), T. Fujisawa (Shizuoka, Japan), Y. Nakamura (Shizuoka, Japan), T. Suda (Shizuoka, Japan), T. Ishida (Okayama, Japan). Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion. 824

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: